Qualisys Holding AB hereby publishes the Interim Report for the period April 1 – June 30, 2026. The Report is available as an attached file to this release and on Qualisys website. Below is a summary of the report.
Seasonal Patterns, Steady Progress
The second quarter brought steady progress, consistent with the seasonal pattern typical of our institutional and academic customer base - a slower start followed by building momentum.
Order intake is steadily building as we enter the third quarter. At similar levels to the comparable period last year and consistent with the seasonal patterns we've seen in previous years, giving us confidence as we head into the second half of 2026.
A major highlight of the quarter was the introduction of Prisma Pose, our new markerless skeletal tracking solution built directly into Qualisys Track Manager (QTM). Prisma Pose gives biomechanics laboratories a practical way to capture motion without markers - with no additional software or hardware investment required. Together with OnTraq for elite sport and our partnership with Theia for more advanced needs, Qualisys now offers a complete suite of markerless solutions tailored to each organization's needs.
The second half of the year is typically our strongest period. With macroeconomic conditions gradually improving, we expect this tailwind to further support performance in the coming quarters. We remain committed to disciplined profitability while continuing to invest in the organization to deliver long-term value.
Second Quarter (April-June)
- Net sales amounted to SEK 54.4 million (55.7), corresponding to a decrease of 2.4 percent (currency-adjusted +3.5 percent).
- Operating profit (EBIT) amounted to SEK 4.0 million (3.4).
- Net profit amounted to SEK 4.1 million (2.8).
- Earnings per share of SEK 0.41 (0.28).
- Cash flow from operating activities after investments amounted to SEK 2.7 million (9.1).
First Half of 2026 (January-June)
- Net sales amounted to SEK 94.4 million (114.7), corresponding to a decrease of 17.7 percent (currency-adjusted -15.6 percent).
- Operating profit (EBIT) amounted to SEK 0.4 million (9.1).
- Net profit amounted to SEK 0.5 million (4.0).
- Earnings per share of SEK 0.05 (0.40).
- Cash flow from operating activities after investments amounted to SEK 2.8 million (6.8).
For further information, please contact:
Magnus Holm, CFO
E-mail: Magnus.Holm@qualisys.com
Ingemar Pettersson, CEO
E-mail: Ingemar.Pettersson@qualisys.se
About Qualisys Holding AB (publ)
Qualisys is a leading provider of motion capture technology and has a long history of supplying research, engineering, entertainment, and sports facilities with high-end camera systems and expertise in capturing and analyzing movements. Qualisys offers a wide range of products and services with its headquarter in Gothenburg, Sweden, and operations in Chicago, Singapore, Shanghai and Delhi. Qualisys is certified according to ISO 9001:2015 and ISO 27001:2023. The clinical products are compliant with Medical Device Directive 93/42/EEC and have FDA clearance (K171547).
Qualisys is listed on Nasdaq First North Premier Growth Market. The company’s Certified Adviser is Svensk Kapitalmarknadsgranskning AB.
This information is information that Qualisys Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-08-26 08:30 CEST.